MEHAOTCMedicinal Chemicals & Botanical ProductsUS GAAP · USD

Functional Brands Inc.

Functional Brands Inc. manufactures and distributes over-the-counter nutraceutical supplements in a range of wellness categories, including pain, energy, prenatal, immunity, sleep, and digestive health. The company sells primarily to end consumers through pharmacies, U.S. wholesalers, international distributors, and direct-to-consumer channels.

Revenue6.6m USD
+0.7 %y/y
Operating profit (EBIT)-1.4m USD
−510.5 %y/y
EBIT margin-21.2%
−17.7 ppy/y
Net income0.8m USD
+235.6 %y/y
Free cash flow-1.3m USD
−1,174,464.2 %y/y

Fiscal year 2025 · change from previous year

Development 2024–2025

-202468m USD2024: 6.6 m USD2024: EBIT -0.23 m USD20242025: 6.6 m USD2025: EBIT -1.4 m USD20256.6-1.4
RevenueOperating profit (EBIT)

Business

Share of revenue
Core nutraceutical supplements100 %

OTC supplement products sold across wellness and preventive health categories.

Products

Reported · share of revenue
98.1%FY2025100 %
  • Nutraceuticalsupplements98.1 %
  • Hemp Derived Products1.9 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

The company serves end consumers who buy supplements for everyday wellness, symptom relief, and preventive health support. Demand flows through pharmacies, U.S. wholesalers, international distributors, and direct-to-consumer channels, so the customer base includes both retail buyers and channel partners that resell to consumers.

End consumers

Buy OTC supplements for pain, sleep, immunity, energy, and general wellness.

Pharmacies

Purchase products for retail shelves and repeat consumer demand.

U.S. wholesalers

Buy in bulk to distribute products into downstream retail channels.

International distributors

Import and resell supplements in non-U.S. markets.

Direct-to-consumer shoppers

Purchase online, supporting growth in the company's DTC channel.

Strategy

Management is focused on growing revenue through direct-to-consumer demand while maintaining distribution through pharmacies, wholesalers, and international partners. The company also appears to be tightening cost controls and negotiating better vendor terms, which supports gross margin improvement in a small-scale consumer health business.

Grow direct-to-consumer salesShort term

The 10-Q says revenue growth was primarily driven by DTC demand, making this the clearest growth lever.

Strengthen channel mixMedium term

Selling through pharmacies, wholesalers, and distributors reduces reliance on one route to market.

Improve margin disciplineShort term

A small revenue base makes cost control and vendor terms important to operating leverage.

Geography

The company is based in the United States and appears to operate primarily from the U.S. market, with additional sales through international distributors. The filings do not disclose a country-by-country revenue split, so the geographic profile should be viewed as U.S.-centric with some export exposure rather than a fully diversified global footprint.

Risks

Functional Brands faces the typical risks of a small consumer health and supplement business: demand volatility, marketing dependence, and inventory obsolescence. The filing also highlights judgment-heavy accounting areas such as goodwill, long-lived assets, and provisions, which can create earnings volatility if assumptions weaken or assets underperform.

Sorted by severity
Goodwill and long-lived asset impairmentHigh

Management explicitly cites recoverability of goodwill and long-lived assets as critical estimates.

ExposurePropertyEquipmentIntangible assets could be impaired if cash flows weaken
Demand and channel concentrationHigh

Revenue growth was primarily driven by direct-to-consumer demand, making the business sensitive to channel performance.

Exposure: DTC and consumer wellness demand

Inventory obsolescenceMedium

Supplements have shelf-life and demand uncertainty, so excess or aged inventory may need write-downs.

ExposureInventory reserve increased to $77722 at Sep. 302025
Financing and interest expenseMedium

Interest expense increased materially in the quarter and nine-month period, indicating financing cost sensitivity.

Exposure: Convertible debenture and other financing instruments

Accounting

Judgemental items
Inventory obsolescence reserve

Management estimates write-downs based on demand, shelf life, and aged stock.

Impact: Directly affects cost of goods sold and gross margin

Goodwill and long-lived asset impairment

Recoverability depends on future cash flow assumptions and fair value estimates.

Impact: Can create material non-cash charges

Fair value of convertible debentures and warrants

Equity-linked financing instruments require valuation analysis and can move earnings.

Impact: Affects other income/expense and balance-sheet carrying values

Lease accounting

Discount rate assumptions affect right-of-use assets and lease liabilities.

Impact: Impacts leverage metrics and depreciation/interest split

Provisions and contingencies

Management must estimate uncertain obligations and potential claims.

Impact: Can affect liabilities and period expense

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

Functional Brands Inc. (OTC) – Medicinal Chemicals & Botanical Products | Financial Analysis – Clarifo